Research Progress of Effect of Inflammatory Bowel Disease on Periodontal Disease

doi:10.13701/j.cnki.kqyxyj.2021.06.004

Abstract

Abstract: Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract. Except for predominant bowel symptoms, patients may also have oral manifestations, of which periodontal disease has gained increasing attention. The pathogeneses of IBD and periodontal disease can both be related to disturbance of local microbial and immune homeostasis. Therefore, the purpose of this paper is to summarize the evidences and possible mechanisms of the effect IBD may have on periodontal disease.

Key words: inflammatory bowel disease, periodontal disease, microbe, immune response

LIN Shulan, ZHAO Lei. Research Progress of Effect of Inflammatory Bowel Disease on Periodontal Disease[J]. Journal of Oral Science Research, 2021, 37(6): 497-500.

References

[1] Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease-epidemiology, genetics, and pathogenesis [J]. Expert Rev Gastroenterol Hepatol, 2019, 13(4):307-317.
[2] Tan CX, Brand HS, de Boer NK, et al. Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn's disease [J]. Br Dent J, 2016, 221(12):794-799.
[3] Tan CX, Brand HS, de Boer NK, et al. Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis [J]. Br Dent J, 2017, 222(1):53-57.
[4] Yang H, Xiao L, Zhang L, et al. Epidemic trend of periodontal disease in elderly Chinese population, 1987-2015: a systematic review and meta-analysis [J]. Sci Rep, 2017, 7:45000.
[5] Liccardo D, Cannavo A, Spagnuolo G, et al. Periodontal disease: A risk factor for diabetes and cardiovascular disease [J]. Int J Mol Sci, 2019, 20(6):1414.[6] Lamster I, Sonis S, Hannigan A, et al. An association between Crohn's disease, periodontal disease and enhanced neutrophil function [J]. J Periodontol, 1978, 49(9):475-479.
[7] Zhang L, Gao X, Zhou J, et al. Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease[J]. Int Dent J, 2020, 70(3):227-236.
[8] Vavricka SR, Manser CN, Hediger S, et al. Periodontitis and gingivitis in inflammatory bowel disease: a case-control study [J]. Inflamm Bowel Dis, 2013, 19(13):2768-2777.
[9] Chi YC, Chen JL, Wang LH, et al. Increased risk of periodontitis among patients with Crohn's disease: a population-based matched-cohort study [J]. Int J Colorectal Dis, 2018, 33(10):1437-1444.
[10] Papageorgiou SN, Hagner M, Nogueira AV, et al. Inflammatory bowel disease and oral health: systematic review and a meta-analysis [J]. J Clin Periodontol, 2017, 44(4):382-393.
[11] Habashneh RA, Khader YS, Alhumouz MK, et al. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study [J]. J Periodontal Res, 2012, 47(3):293-298.
[12] Koutsochristou V, Zellos A, Dimakou K, et al. Dental caries and periodontal disease in children and adolescents with inflammatory bowel disease: A case-control study [J]. Inflamm Bowel Dis, 2015, 21(8):1839-1846.
[13] Pietropaoli D, Del Pinto R, Corridoni D, et al. Occurrence of spontaneous periodontal disease in the SAMP1/YitFc murine model of Crohn disease [J]. J Periodontol, 2014, 85(12):1799-1805.
[14] Laranjeira N, Fonseca J, Meira T, et al. Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients [J]. Arq Gastroenterol, 2015, 52(2):105-110.
[15] Lauritano D, Boccalari E, Di Stasio D, et al. Prevalence of oral lesions and correlation with intestinal symptoms of inflammatory bowel disease: a systematic review [J]. Diagnostics (Basel), 2019, 9(3):77.
[16] Kumar KM, Nachiammai N, Madhushankari GS. Association of oral manifestations in ulcerative colitis: A pilot study [J]. J Oral Maxillofac Pathol, 2018, 22(2):199-203.
[17] Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease [J]. Semin Immunopathol, 2015, 37(1):47-55.
[18] Lucas López R, Grande Burgos MJ, Gálvez A, et al. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review [J]. APMIS, 2017, 125(1):3-10.
[19] Van Dyke TE, Dowell VR Jr, Offenbacher S, et al. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease [J]. Infect Immun, 1986, 53(3):671-677.
[20] Brito F, Zaltman C, Carvalho AT, et al. Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis [J]. Eur J Gastroenterol Hepatol, 2013, 25(2):239-245.
[21] Rautava J, Pinnell LJ, Vong L, et al. Oral microbiome composition changes in mouse models of colitis [J]. J Gastroenterol Hepatol, 2015, 30(3):521-527.
[22] Said HS, Suda W, Nakagome S, et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers [J].DNA Res, 2014, 21(1):15-25.
[23] Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease [J]. Front Immunol, 2019, 10:276.
[24] Isaza-Guzmán DM, Medina-Piedrahíta VM, Gutiérrez-Henao C, et al. Salivary levels of NLRP3 inflammasome-related proteins as potential biomarkers of periodontal clinical status [J]. J Periodontol, 2017, 88(12):1329-1338.
[25] Cheng R, Liu W, Zhang R, et al. Porphyromonas gingivalis-derived lipopolysaccharide combines hypoxia to induce Caspase-1 activation in periodontitis [J]. Front Cell Infect Microbiol, 2017, 7:474.
[26] Yoshida K, Okamura H, Hiroshima Y, et al. PKR induces the expression of NLRP3 by regulating the NF-κB pathway in Porphyromonas gingivalis-infected osteoblasts [J]. Exp Cell Res, 2017, 354(1):57-64.
[27] Hanaei S, Sadr M, Rezaei A, et al. Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study [J]. Clin Res Hepatol Gastroenterol, 2018, 42(3):269-275.
[28] Bonilla-León DM, Hurtado-Cadavid MC, Tobón-Arroyave SI. Determination of NLRP3 (rs4612666) and IL-1B (rs1143634) genetic polymorphisms in periodontally diseased and healthy subjects [J]. Arch Oral Biol, 2016, 65:44-51.
[29] Figueredo CM, Brito F, Barros FC, et al. Expression of cytokines in the gingival crevicular fluid and serum from patients with inflammatory bowel disease and untreated chronic periodontitis [J]. J Periodontal Res, 2011, 46(1):141-146.
[30] Ujiie Y, Karakida T, Yamakoshi Y, et al. Interleukin-4 released from human gingival fibroblasts reduces osteoclastogenesis [J]. Arch Oral Biol, 2016, 72:187-193.
[31] Wang F, Guan M, Wei L, et al. IL-18 promotes the secretion of matrix metalloproteinases in human periodontal ligament fibroblasts by activating NF-κB signaling [J]. Mol Med Rep, 2019, 19(1):703-710.
[32] Nair V, Bandyopadhyay P, Kundu D, et al. Estimation of interleukin-18 in the gingival crevicular fluid and serum of Bengali population with periodontal health and disease [J]. J Indian Soc Periodontol, 2016, 20(3):260-264.
[33] Figueredo CM, Martins AP, Lira-Junior R, et al. Activity of inflammatory bowel disease influences the expression of cytokines in gingival tissue [J]. Cytokine, 2017, 95:1-6.
[34] Lamster IB, Rodrick ML, Sonis ST, et al. An analysis of peripheral blood and salivary polymorphonuclear leukocyte function, circulating immune complex levels and oral status in patients with inflammatory bowel disease [J]. J Periodontol, 1982, 53(4):231-238.
[35] Denson LA, Jurickova I, Karns R, et al. Clinical and genomic correlates of neutrophil reactive oxygen species production in pediatric patients with Crohn's disease [J]. Gastroenterology, 2018, 154(8):2097-2110.
[36] White PC, Chicca IJ, Cooper PR, et al. Neutrophil Extracellular Traps in Periodontitis: A Web of Intrigue [J]. J Dent Res, 2016, 95(1):26-34.
[37] Majster M, Almer S, Boström EA. Salivary calprotectin is elevated in patients with active inflammatory bowel disease [J]. Arch Oral Biol, 2019, 107:104528.
[38] Haririan H, Andrukhov O, Pablik E, et al. Comparative analysis of Calcium-binding myeloid-related protein-8/14 in saliva and serum of patients with periodontitis and healthy individuals [J]. J Periodontol, 2016, 87(2):184-192.
[39] Gao H, Hou J, Meng H, et al. Proinflammatory effects and mechanisms of calprotectin on human gingival fibroblasts [J]. J Periodontal Res, 2017, 52(6):975-983.